Abstract
A West African (Hausa) herbal pharmacopoeia is evaluated in the context of potential chemotherapeutic efficacy in the indigenous treatment of malaria. Results are presented from laboratory analyses designed to assess the capacity of medicinal plants to increase intraery‐throcytic oxidation, a phenomenon previously demonstrated to be of therapeutic value in malaria infection. Methodology and data are also discussed in broader contexts which address questions of: effective integration of indigenous and Western treatment modalities; adaptive significance, with respect to health status, for medically related and other (e.g., nutritional) behaviors involving the indigenous use of plants.
Notes
This work was supported in part by a faculty research grant from Memphis State University. The author wishes also to acknowledge the following individuals for their efforts in facilitating various stages of the research and manuscript preparation: Elaine Berger, John Eaton, Natalie Etkin, Peter Goldblatt, Ibrahim Muazzamu, Jinjiri Musa, and Paul Ross.